ANGPTL4 and Lymphadenopathy: It is not yet clear whether a larger sampling of individuals deficient in ANGPTL4 activity would reveal abdominal lymphadenopathy, or whether therapeutic antagonism of ANGPTL4 late in life will have similar effects in humans.